BioKangtai released its performance for the first three quarters, with a net profit attributable to the parent company of 49.1577 million yuan, a decrease of 86%
BioKangtai released its third-quarter report for 2025, with operating revenue for the first three quarters amounting to 2.063 billion yuan, a year-on-year increase of 2.24%. The net profit attributable to the parent company was 49.1577 million yuan, a year-on-year decrease of 86%. The net profit after deducting non-recurring gains and losses was 27.8789 million yuan, a year-on-year decrease of 90.82%. The basic earnings per share were 0.04 yuan
According to the Zhitong Finance APP, BioKangtai (300601.SZ) released its third-quarter report for 2025. The company's operating revenue for the first three quarters was 2.063 billion yuan, a year-on-year increase of 2.24%. The net profit attributable to shareholders of the listed company was 49.1577 million yuan, a year-on-year decrease of 86.00%. The net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 27.8789 million yuan, a year-on-year decrease of 90.82%. The basic earnings per share were 0.04 yuan
